Implementation Guide CH VACD
4.0.1 - trial-use
This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization
Resource Immunization "TCA01-IMMUN3-HCP2-ORG2-ROLE"
Profile: CH VACD Immunization
Author of the content: PractitionerRole/TC-HCP2-ORG2-ROLE-author
CH VACD Extension Immunization Medication Reference: Medication/TC-IMMUN-MEDIC-FSMEIMMCC
identifier: id: 7f7a308a-63f7-4be1-a329-0a33e08b4645
status: completed
vaccineCode: FSME-Immun CC (Swiss Medic Authorized Vaccines Codesystem#450)
patient: Patient/TC-patient " WEGMUELLER"
occurrence: 2021-08-01
recorded: 2021-08-02 00:00:00+0200
lotNumber: 12-34244
route: Intramuscular use (standardterms.edqm.eu#20035000)
Actor |
PractitionerRole/TC-HCP2-ORG2-ROLE-performer |
note: Der Patient hatte keinerlei Nebenwirkungen. (By Practitioner/TC-HCP2-C2 @2021-08-01)
TargetDisease | DoseNumber[x] |
Tickborne encephalitis (SNOMED CT#712986001) | 1 |